Your browser doesn't support javascript.
loading
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.
Kasenda, B; Schorb, E; Fritsch, K; Finke, J; Illerhaus, G.
Affiliation
  • Kasenda B; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
  • Schorb E; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.
  • Fritsch K; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.
  • Finke J; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.
  • Illerhaus G; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.
Ann Oncol ; 26(3): 608-11, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25725080

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Switzerland